Soluble human complement receptor type 1 inhibits complement-mediated host defense.

Soluble complement receptor type 1 (sCR1) is a powerful inhibitor of complement activation. Because of this ability, sCR1 may prove to be an important therapeutic agent that can be used to block the immunopathologic effects of uncontrolled complement activation in a variety of clinically significant...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	Clin Diagn Lab Immunol
Hoofdauteurs:	Swift, A J, Collins, T S, Bugelski, P, Winkelstein, J A
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	American Society for Microbiology (ASM) 1994
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368344/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8556505/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.1.5.585-589.1994
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!